Showing results (121-130 of 172) with videos related to

Sort By:
Pageof 18
American Journal of Cancer Research|February 7, 2024
Urinary volatile organic compounds in prostate cancer biopsy pathologic risk stratification using logistic regression and multivariate analysis modelsSabur Badmos, Elizabeth Noriega-Landa, Kiana L Holbrook, et al.
The Journal of Urology|September 6, 2017
Incidence, Clinicopathological Risk Factors, Management and Outcomes of Nonmuscle Invasive Recurrence after Complete Response to Trimodality Therapy for Muscle Invasive Bladder CancerAlejandro Sanchez, Matthew F Wszolek, Andrzej Niemierko, et al.
American Journal of Medical Genetics. Part A|September 15, 2021
A truncating NRIP1 variant in an Arabic family with congenital anomalies of the kidneys and urinary tractBixia Zheng, Chunyan Wang, Steve Seltzsam, et al.
European Urology|September 18, 2020
Biopsy Cell Cycle Proliferation Score Predicts Adverse Surgical Pathology in Localized Renal Cell CarcinomaJeffrey J Tosoian, Adam S Feldman, Madeline R Abbott, et al.
JAMA Network Open|May 19, 2023
Association of BCG Vaccine Treatment With Death and Dementia in Patients With Non-Muscle-Invasive Bladder CancerMarc S Weinberg, Affan Zafar, Colin Magdamo, et al.
Neurourology and Urodynamics|February 19, 2021
Losartan prevents bladder fibrosis and protects renal function in rat with neurogenic paralysis bladderYu L He, Jian G Wen, Qing S Pu, et al.
Urologic Oncology|June 11, 2015
Active surveillance for low-risk prostate cancer: Need for intervention and survival at 10 yearsMark A Preston, Adam S Feldman, John J Coen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 2, 2021
Whole-exome sequencing identifies FOXL2, FOXA2 and FOXA3 as candidate genes for monogenic congenital anomalies of the kidneys and urinary tractBixia Zheng, Steve Seltzsam, Chunyan Wang, et al.
Urologic Oncology|May 19, 2023
Impact of a negative confirmatory biopsy on risk of disease progression among men on active surveillance for prostate cancerKeyan Salari, Jason Kowitz, Jeffrey Twum-Ampofo, et al.
Oncotarget|April 19, 2014
Strigolactone analogues induce apoptosis through activation of p38 and the stress response pathway in cancer cell lines and in conditionally reprogrammed primary prostate cancer cellsClaire B Pollock, Sara McDonough, Victor S Wang, et al.
Pageof 18